Bionomics Ltd B1N-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 02/26/21 CET
0.268quote price arrow up+0.026 (+10.74%)
Volume
423,563
52 week range
0.01 - 0.27

...

Loading . . .

KEY STATS

  • Open0.242
  • Day High0.27
  • Day Low0.238
  • Prev Close0.268
  • 52 Week High0.27
  • 52 Week High Date02/26/21
  • 52 Week Low0.01
  • 52 Week Low Date03/26/20
  • Market Cap182.65M
  • Shares Out664.32M
  • 10 Day Average Volume1.01M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change1,192.19

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Bionomics Ltd News

There is no recent news for this security.

Latest B1N-FF News From Our Partners

February 13, 2021

QUOTE FINDER

Profile

MORE
Bionomics Limited is a clinical-stage biopharmaceutical company engaged in discovery and development of drug candidates focused on the treatment of central nervous system (CNS) disorders and cancer by using its platform technologies. The Company's segments include Drug discovery and development, and Contract services. The Drug discovery and development segment includes the discovery, development and commercialization of compounds to match a target product profile. The...
Errol De Souza Ph.D.
Chairman
Adrian Hinton
Chief Financial Officer
Liz Doolin
Vice President
Address
31 Dalgleish St
Thebarton, SA
5031
Australia